PAVM PAVmed Inc

Price (delayed)

$1.725

Market cap

$15.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.16

Enterprise value

$44.91M

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital ...

Highlights
PAVM's gross margin has surged by 81% year-on-year and by 50% since the previous quarter
PAVmed's revenue has soared by 62% from the previous quarter
The debt has grown by 33% YoY but it has contracted by 2.4% from the previous quarter
PAVM's gross profit is down by 23% year-on-year but it is up by 19% since the previous quarter
PAVM's quick ratio has dropped by 63% year-on-year and by 27% since the previous quarter
The equity has declined by 24% since the previous quarter

Key stats

What are the main financial stats of PAVM
Market
Shares outstanding
9.17M
Market cap
$15.82M
Enterprise value
$44.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
5.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.31
Earnings
Revenue
$2.45M
EBIT
-$63.59M
EBITDA
-$60.35M
Free cash flow
-$51.28M
Per share
EPS
-$9.16
Free cash flow per share
-$7.09
Book value per share
-$6.69
Revenue per share
$0.34
TBVPS
$4.38
Balance sheet
Total assets
$33.12M
Total liabilities
$57.14M
Debt
$48.73M
Equity
-$53.83M
Working capital
-$29.68M
Liquidity
Debt to equity
-0.91
Current ratio
0.45
Quick ratio
0.36
Net debt/EBITDA
-0.48
Margins
EBITDA margin
-2,461.1%
Gross margin
-161.8%
Net margin
-2,617.3%
Operating margin
-2,805.7%
Efficiency
Return on assets
-136.6%
Return on equity
N/A
Return on invested capital
-649.6%
Return on capital employed
N/A
Return on sales
-2,593.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PAVM stock price

How has the PAVmed stock price performed over time
Intraday
-2.54%
1 week
-7.26%
1 month
-16.26%
1 year
-75.44%
YTD
-58.13%
QTD
-19.39%

Financial performance

How have PAVmed's revenue and profit performed over time
Revenue
$2.45M
Gross profit
-$3.97M
Operating income
-$68.8M
Net income
-$64.18M
Gross margin
-161.8%
Net margin
-2,617.3%
The net margin has soared by 89% YoY and by 44% from the previous quarter
The operating margin has surged by 88% year-on-year and by 45% since the previous quarter
PAVM's gross margin has surged by 81% year-on-year and by 50% since the previous quarter
PAVmed's revenue has soared by 62% from the previous quarter

Growth

What is PAVmed's growth rate over time

Valuation

What is PAVmed stock price valuation
P/E
N/A
P/B
N/A
P/S
5.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.31
The EPS is up by 39% year-on-year and by 13% since the previous quarter
The equity has declined by 24% since the previous quarter
The stock's price to sales (P/S) is 86% less than its last 4 quarters average of 36.1
PAVmed's revenue has soared by 62% from the previous quarter

Efficiency

How efficient is PAVmed business performance
The ROS has soared by 89% year-on-year and by 44% since the previous quarter
The company's return on invested capital has surged by 65% YoY and by 10% QoQ
PAVM's return on assets is down by 12% year-on-year and by 3.6% since the previous quarter

Dividends

What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PAVM.

Financial health

How did PAVmed financials performed over time
The total assets is 42% less than the total liabilities
PAVM's quick ratio has dropped by 63% year-on-year and by 27% since the previous quarter
PAVmed's current ratio has shrunk by 58% YoY and by 25% QoQ
The debt is 191% more than the equity
PAVM's debt to equity has surged by 76% year-on-year and by 21% since the previous quarter
The debt has grown by 33% YoY but it has contracted by 2.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.